These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Swe TT, Onitsuka H, Kawamoto K, Ueyama T, Tsuruchi N, Masuda K. Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735 [Abstract] [Full Text] [Related]
24. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. Thomassin-Naggara I, Daraï E, Nassar-Slaba J, Cortez A, Marsault C, Bazot M. J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760 [Abstract] [Full Text] [Related]
25. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E, Libera H, Kimmig R, Forsting M. Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [Abstract] [Full Text] [Related]
29. [Clinical application of magnetic resonance imaging in gynecology]. Zou SS. Zhonghua Fu Chan Ke Za Zhi; 1989 Jan; 24(1):19-21, 58. PubMed ID: 2758899 [Abstract] [Full Text] [Related]
30. Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors. Shimada K, Ohashi I, Kasahara I, Watanabe H, Ohta S, Miyasaka N, Itoh E, Shibuya H. J Magn Reson Imaging; 2004 Jul; 20(1):97-104. PubMed ID: 15221814 [Abstract] [Full Text] [Related]